134 related articles for article (PubMed ID: 37840385)
1. EED related overgrowth: First report of multiple members in a single family.
Goel H; O'Donnell S; Edwards M
Am J Med Genet A; 2024 Feb; 194(2):374-382. PubMed ID: 37840385
[TBL] [Abstract][Full Text] [Related]
2. PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes.
Cyrus S; Burkardt D; Weaver DD; Gibson WT
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):519-531. PubMed ID: 31724824
[TBL] [Abstract][Full Text] [Related]
3. Manifestation of epilepsy in a patient with EED-related overgrowth (Cohen-Gibson syndrome).
Hetzelt KLML; Winterholler M; Kerling F; Rauch C; Ekici AB; Winterpacht A; Vasileiou G; Uebe S; Thiel CT; Kraus C; Reis A; Zweier C
Am J Med Genet A; 2022 Jan; 188(1):292-297. PubMed ID: 34533271
[TBL] [Abstract][Full Text] [Related]
4. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome.
Imagawa E; Higashimoto K; Sakai Y; Numakura C; Okamoto N; Matsunaga S; Ryo A; Sato Y; Sanefuji M; Ihara K; Takada Y; Nishimura G; Saitsu H; Mizuguchi T; Miyatake S; Nakashima M; Miyake N; Soejima H; Matsumoto N
Hum Mutat; 2017 Jun; 38(6):637-648. PubMed ID: 28229514
[TBL] [Abstract][Full Text] [Related]
5. Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder.
Imagawa E; Seyama R; Aoi H; Uchiyama Y; Marcarini BG; Furquim I; Honjo RS; Bertola DR; Kim CA; Matsumoto N
Clin Genet; 2023 Apr; 103(4):383-391. PubMed ID: 36645289
[TBL] [Abstract][Full Text] [Related]
6. EED and EZH2 constitutive variants: A study to expand the Cohen-Gibson syndrome phenotype and contrast it with Weaver syndrome.
Griffiths S; Loveday C; Zachariou A; Behan LA; Chandler K; Cole T; D'Arrigo S; Dieckmann A; Foster A; Gibney J; Hunter M; Milani D; Pantaleoni C; Roche E; Sherlock M; Springer A; White SM; ; Tatton-Brown K
Am J Med Genet A; 2019 Apr; 179(4):588-594. PubMed ID: 30793471
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.
Choufani S; Gibson WT; Turinsky AL; Chung BHY; Wang T; Garg K; Vitriolo A; Cohen ASA; Cyrus S; Goodman S; Chater-Diehl E; Brzezinski J; Brudno M; Ming LH; White SM; Lynch SA; Clericuzio C; Temple IK; Flinter F; McConnell V; Cushing T; Bird LM; Splitt M; Kerr B; Scherer SW; Machado J; Imagawa E; Okamoto N; Matsumoto N; Testa G; Iascone M; Tenconi R; Caluseriu O; Mendoza-Londono R; Chitayat D; Cytrynbaum C; Tatton-Brown K; Weksberg R
Am J Hum Genet; 2020 May; 106(5):596-610. PubMed ID: 32243864
[TBL] [Abstract][Full Text] [Related]
8. Rare SUZ12 variants commonly cause an overgrowth phenotype.
Cyrus SS; Cohen ASA; Agbahovbe R; Avela K; Yeung KS; Chung BHY; Luk HM; Tkachenko N; Choufani S; Weksberg R; Lopez-Rangel E; ; Brown K; Saenz MS; Svihovec S; McCandless SE; Bird LM; Garcia AG; Gambello MJ; McWalter K; Schnur RE; An J; Jones SJM; Bhalla SK; Pinz H; Braddock SR; Gibson WT
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):532-547. PubMed ID: 31736240
[TBL] [Abstract][Full Text] [Related]
9. Three additional patients with EED-associated overgrowth: potential mutation hotspots identified?
Spellicy CJ; Peng Y; Olewiler L; Cathey SS; Rogers RC; Bartholomew D; Johnson J; Alexov E; Lee JA; Friez MJ; Jones JR
J Hum Genet; 2019 Jun; 64(6):561-572. PubMed ID: 30858506
[TBL] [Abstract][Full Text] [Related]
10. Loss of maternal EED results in postnatal overgrowth.
Prokopuk L; Stringer JM; White CR; Vossen RHAM; White SJ; Cohen ASA; Gibson WT; Western PS
Clin Epigenetics; 2018 Jul; 10(1):95. PubMed ID: 30005706
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
12. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
Cohen AS; Yap DB; Lewis ME; Chijiwa C; Ramos-Arroyo MA; Tkachenko N; Milano V; Fradin M; McKinnon ML; Townsend KN; Xu J; Van Allen MI; Ross CJ; Dobyns WB; Weaver DD; Gibson WT
Hum Mutat; 2016 Mar; 37(3):301-7. PubMed ID: 26694085
[TBL] [Abstract][Full Text] [Related]
13. Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty.
Okamoto N; Yoshida S; Ogitani A; Etani Y; Yanagi K; Kaname T
Am J Med Genet A; 2024 May; ():e63726. PubMed ID: 38814056
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
[TBL] [Abstract][Full Text] [Related]
15. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
[TBL] [Abstract][Full Text] [Related]
16. Identification of catalytic and non-catalytic activity inhibitors against PRC2-EZH2 complex through multiple high-throughput screening campaigns.
Zhou Y; Du DH; Wang J; Cai XQ; Deng AX; Nosjean O; Boutin JA; Renard P; Yang DH; Luo C; Wang MW
Chem Biol Drug Des; 2020 Oct; 96(4):1024-1051. PubMed ID: 32394628
[TBL] [Abstract][Full Text] [Related]
17. Non-canonical transcriptional regulation of INHAT subunit SET/TAF-Iβ by EZH2.
Hwang IJ; Park J; Seo SB
Biochem Biophys Res Commun; 2022 Dec; 635():136-143. PubMed ID: 36274363
[TBL] [Abstract][Full Text] [Related]
18. EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance.
Chu L; Tan D; Zhu M; Qu Y; Ma X; Song BL; Qi W
J Biol Chem; 2023 Apr; 299(4):103073. PubMed ID: 36858198
[TBL] [Abstract][Full Text] [Related]
19. Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival.
Karlowee V; Amatya VJ; Takayasu T; Takano M; Yonezawa U; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
Pathobiology; 2019; 86(2-3):152-161. PubMed ID: 31096221
[TBL] [Abstract][Full Text] [Related]
20. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
Tatton-Brown K; Loveday C; Yost S; Clarke M; Ramsay E; Zachariou A; Elliott A; Wylie H; Ardissone A; Rittinger O; Stewart F; Temple IK; Cole T; ; Mahamdallie S; Seal S; Ruark E; Rahman N
Am J Hum Genet; 2017 May; 100(5):725-736. PubMed ID: 28475857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
